| Dr Manouchehr Pouresmail, DMD, DDS, MSC | |
|
106 Gateway Center Dr, Suite D, Paso Robles, CA 93446-3754 | |
| (805) 237-7668 | |
| (805) 237-7663 |
| Full Name | Dr Manouchehr Pouresmail |
|---|---|
| Gender | Male |
| Speciality | Dentist - Endodontics |
| Location | 106 Gateway Center Dr, Paso Robles, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1134306277 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1223E0200X | Dentist - Endodontics | 51294 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Manouchehr Pouresmail, DMD, DDS, MSC 12300 Stonington St, Bakersfield, CA 93312-5794 Ph: (909) 800-5975 | Dr Manouchehr Pouresmail, DMD, DDS, MSC 106 Gateway Center Dr, Suite D, Paso Robles, CA 93446-3754 Ph: (805) 237-7668 |
News Archive
Allergan plc, a leading global pharmaceutical company, today announced that it has launched a generic version of Janssen's INVEGA (paliperidone extended-release tablets) in the U.S. Allergan is the first company to receive FDA approval for and launch a generic version of INVEGA, demonstrating the deep expertise of the Company's global generics R&D, regulatory and supply chain teams.
ZaBeCor Pharmaceuticals ("ZaBeCor" or the "Company") announced today the initiation of a Phase II clinical trial for its asthma drug candidate Excellair™, following the successful results of the Company's Phase I clinical trials. ZaBeCor is one of the first companies to deliver siRNA to the lung and one of the first to target asthma with siRNA.
Researchers at the Wellcome Trust Sanger Institute have discovered 'hotspots' of mutations in breast cancer genomes, where mutations thought to be inactive 'passengers' in the genome have now been shown to possibly drive further cancerous changes.
Two types of stent systems are both effective in treating patients who have severe forms of peripheral artery disease (PAD), according to results of the MOBILITY trial presented today as a late-breaking clinical trial at the SCAI 2012 Scientific Sessions.
New study challenges long-standing assumptions about disease severity in infants, and suggests that standard qPCR interpretations underestimate the true burden of other highly contagious diseases, such as COVID-19 and influenza.
› Verified 6 days ago
Dr. Duffy Charles De Graw, D.D.S. Dentist Medicare: Not Enrolled in Medicare Practice Location: 922 Walnut Dr, Paso Robles, CA 93446 Phone: 805-226-9808 | |
A. Keyla Springe, D.D.S. Dentist Medicare: Not Enrolled in Medicare Practice Location: 143 Niblick Rd, Paso Robles, CA 93446 Phone: 805-226-8126 | |
Edith Pallencaoe, DDS Dentist Medicare: Medicare Enrolled Practice Location: 502 First St, Ste. B, Paso Robles, CA 93446 Phone: 805-239-9597 Fax: 805-239-4142 | |
Dr. Don R Miller, D.D.S. Dentist Medicare: Not Enrolled in Medicare Practice Location: 1115 Vine St, Paso Robles, CA 93446 Phone: 805-238-2632 Fax: 805-238-6027 | |
Dr. James Robert Oates, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 7750 Sundance Trl, Paso Robles, CA 93446 Phone: 805-237-1523 | |
David Scott Shampain, D.D.S. Dentist Medicare: Medicare Enrolled Practice Location: 1920 Creston Rd, Suite B, Paso Robles, CA 93446 Phone: 805-239-2146 Fax: 805-239-9097 |